| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 05/16/2023 | Viking Therapeutics, Inc. | VKTX | Exercise | Stock Option (Right to Buy) | 16k | $1.19 | $19k | | 05/16/2023 |
| 05/16/2023 | Viking Therapeutics, Inc. | VKTX | Sale | Common Stock, par value $0.00001 per share | 16k | $24.00 | $384k | | 05/16/2023 |
| 01/03/2023 | Viking Therapeutics, Inc. | VKTX | Grant | Stock Option (Right to Buy) | 22k | $8.52 | $187.4k | | 01/03/2023 |
| 01/03/2022 | Viking Therapeutics, Inc. | VKTX | Grant | Stock Option (Right to Buy) | 22k | $4.88 | $107.4k | | 01/03/2022 |
| 01/02/2020 | Viking Therapeutics, Inc. | VKTX | Grant | Stock Option (Right to Buy) | 22k | $7.95 | $174.9k | | 01/02/2020 |
| 01/02/2019 | Viking Therapeutics, Inc. | VKTX | Grant | Stock Option (Right to Buy) | 22k | $8.32 | $183k | | 01/02/2019 |
| 05/29/2018 | Viking Therapeutics, Inc. | VKTX | Purchase | Common Stock, par value $0.00001 per share | 48k | $5.22 | $250.3k | | 05/29/2018 |
| 01/02/2018 | Viking Therapeutics, Inc. | VKTX | Grant | Stock Option (Right to Buy) | 16k | $4.48 | $71.7k | | 01/02/2018 |